OliX

CompanySouth Korea

OliX develops one asset, in phase 2 (OLX10212 in geographic atrophy). Mostly oligonucleotide; based in South Korea.

1
Asset
Furthest stage
Phase 2
0
Trials
1
Signal

Pipeline

1
  • OLX10212

    Phase 2, Oligonucleotide, geographic atrophy, macular degeneration

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Signals1
  • Similar companies6

Intelligence